Catherine Sazdanoff

Insider Reports History

Location
Cincinnati, OH
Signature
/s/ F. Mark Reuter, as Attorney-in-fact for Catherine Sazdanoff
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Catherine Sazdanoff:

Form 4 holding Director

InMed Pharmaceuticals Inc.

Security class
Employee Stock Option (Right to Buy)
Shares / value
29,091
Estimated value
Report date
29 Dec 2021
Price
Ownership
Direct
Underlying class
Common shares
Underlying amount
Form 4 holding Director

MERIDIAN BIOSCIENCE INC

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
31 Jan 2023
Price
$13.25
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Catherine Sazdanoff

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .